This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Adams, A. S. Articles by Ross-Degnan, D. Search for Related Content PubMed PubMed Citation Articles by Adams, A. S. Articles by Ross-Degnan, D. Related Collections Managed Care - Medicare Medicare Pharmaceuticals

DataWatch

Use Of Antihypertensive Drugs By Medicare Enrollees: Does Type Of Drug Coverage Matter?

Research has demonstrated that Medicare beneficiaries with drug coverage consume more clinically essential drugs. However, generosity of coverage varies considerably across beneficiaries. This study examines the association between types of drug coverage and the consumption and cost per tablet of essential antihypertensive medications among beneficiaries with hypertension. The findings indicate that while both state- and employer-sponsored drug coverage are associated with greater consumption of antihypertensive drugs and lower out-of-pocket costs per tablet, private supplemental coverage is not associated with greater use and is associated with only slightly lower out-of-pocket costs than among noncovered beneficiaries.

                      What's this?

This article has been cited by other articles:

				Z. Yang, D. B. Gilleskie, and E. C. Norton Health Insurance, Medical Care, and Health Outcomes: A Model of Elderly Health Dynamics J. Human Resources, January 1, 2009; 44(1): 47 - 114. [Abstract] [PDF]

				J. M. Madden, A. J. Graves, F. Zhang, A. S. Adams, B. A. Briesacher, D. Ross-Degnan, J. H. Gurwitz, M. Pierre-Jacques, D. G. Safran, G. S. Adler, et al. Cost-Related Medication Nonadherence and Spending on Basic Needs Following Implementation of Medicare Part D JAMA, April 23, 2008; 299(16): 1922 - 1928. [Abstract] [Full Text] [PDF]

				S. B. Soumerai, M. Pierre-Jacques, F. Zhang, D. Ross-Degnan, A. S. Adams, J. Gurwitz, G. Adler, and D. G. Safran Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med, September 25, 2006; 166(17): 1829 - 1835. [Abstract] [Full Text] [PDF]

				T. Rice and K. Y. Matsuoka Book Review: The Impact of Cost-Sharing on Appropriate Utilization and Health Status: A Review of the Literature on Seniors Med Care Res Rev, December 1, 2004; 61(4): 415 - 452. [Abstract] [PDF]

				C.-W. Tseng, R. H. Brook, E. Keeler, W. N. Steers, and C. M. Mangione Cost-Lowering Strategies Used by Medicare Beneficiaries Who Exceed Drug Benefit Caps and Have a Gap in Drug Coverage JAMA, August 25, 2004; 292(8): 952 - 960. [Abstract] [Full Text] [PDF]

				C.-W. Tseng, R. H. Brook, E. Keeler, and C. M. Mangione Impact of an Annual Dollar Limit or "Cap" on Prescription Drug Benefits for Medicare Patients JAMA, July 9, 2003; 290(2): 222 - 227. [Abstract] [Full Text] [PDF]

				A. D. Federman, A. S. Adams, D. Ross-Degnan, S. B. Soumerai, and J. Z. Ayanian Supplemental Insurance and Use of Effective Cardiovascular Drugs Among Elderly Medicare Beneficiaries With Coronary Heart Disease JAMA, October 10, 2001; 286(14): 1732 - 1739. [Abstract] [Full Text] [PDF]